These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22971750)

  • 1. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs genetic polymorphisms and plasma levels in hypertensive disorders of pregnancy.
    Luizon MR; Amaral LM; Palei AC
    J Hum Hypertens; 2013 Apr; 27(4):278-9. PubMed ID: 22971750
    [No Abstract]   [Full Text] [Related]  

  • 2. Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.
    Karthikeyan VJ; Lane DA; Beevers DG; Lip GY; Blann AD
    J Hum Hypertens; 2013 Feb; 27(2):72-8. PubMed ID: 22418748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated expression of matrix metalloproteinases and their inhibitors may participate in the pathogenesis of pre-eclampsia and fetal growth restriction.
    Zhu J; Zhong M; Pang Z; Yu Y
    Early Hum Dev; 2014 Oct; 90(10):657-64. PubMed ID: 25194834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Matrix metalloproteinases and their tissue inhibitors].
    Trojanek J
    Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications.
    Cockle JV; Gopichandran N; Walker JJ; Levene MI; Orsi NM
    Reprod Sci; 2007 Oct; 14(7):629-45. PubMed ID: 18000225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the dysregulation of matrix metalloproteinases contribute to recurrent implantation failure?
    Benkhalifa M; Zayani Y; Bach V; Copin H; Feki M; Benkhalifa M; Allal-Elasmi M
    Expert Rev Proteomics; 2018 Apr; 15(4):311-323. PubMed ID: 29648896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.
    Mroczko B; Groblewska M; Barcikowska M
    J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases of normal human tissues.
    Khasigov PZ; Podobed OV; Ktzoeva SA; Gatagonova TM; Grachev SV; Shishkin SS; Berezov TT
    Biochemistry (Mosc); 2001 Feb; 66(2):130-40. PubMed ID: 11255119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of matrix metalloproteinases and their tissue inhibitors by S100A4.
    Elenjord R; Ljones H; Sundkvist E; Loennechen T; Winberg JO
    Connect Tissue Res; 2008; 49(3):185-8. PubMed ID: 18661339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling.
    Castro MM; Rizzi E; Prado CM; Rossi MA; Tanus-Santos JE; Gerlach RF
    Matrix Biol; 2010 Apr; 29(3):194-201. PubMed ID: 19969080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and pre-eclampsia.
    Merchant SJ; Davidge ST
    BJOG; 2004 Sep; 111(9):931-9. PubMed ID: 15327607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and their inhibitors in exfoliation syndrome.
    Gartaganis SP; Georgakopoulos CD; Mela EK; Exarchou A; Ziouti N; Assouti M; Vynios DH
    Ophthalmic Res; 2002; 34(3):165-71. PubMed ID: 12097800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic in vivo changes in the activities of gelatinases, matrix metalloproteinases (MMPs), and tissue inhibitor of metalloproteinases (TIMPs) in buffalo (Bubalus bubalis) uterine luminal fluid during estrous cycle and early pregnancy.
    Roy SC; Ghosh J
    Mol Reprod Dev; 2010 Nov; 77(11):944-53. PubMed ID: 20886603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights into the Role of Matrix Metalloproteinases in Preeclampsia.
    Espino Y Sosa S; Flores-Pliego A; Espejel-Nuñez A; Medina-Bastidas D; Vadillo-Ortega F; Zaga-Clavellina V; Estrada-Gutierrez G
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
    Groblewska M; Siewko M; Mroczko B; Szmitkowski M
    Folia Histochem Cytobiol; 2012 Apr; 50(1):12-9. PubMed ID: 22532131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and their inhibitors at the feto-maternal interface in unruptured ectopic tubal pregnancy.
    Qiu X; Xie Y; Chen L; Gemzell-Danielsson K
    Acta Obstet Gynecol Scand; 2011 Sep; 90(9):966-71. PubMed ID: 21644936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of matrix metalloproteinase secretion by adenosine A3 receptor in preeclamptic villous explants.
    Kim YH; Hwang HS; Kim YT; Kim HS; Park YW
    Reprod Sci; 2008 Nov; 15(9):939-49. PubMed ID: 19050327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.